8 February 2021Algernon Pharmaceuticals (AGN.C) taps Charles River Technologies for DMT pre-clinicalsJoseph Morton AGN.C Algernon Pharmaceuticals (AGN.C) and Charles River Laboratories agreed to have the latter handle Algernon’s DMT pre-clinical studies for their stroke clinical research program today, according to a press release….